IBRX
ImmunityBio Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$8.39
+0.57 ▲ +7.29%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$8.41
+0.02 ▲ +0.24%
| Index | RUT | P/E | - | EPS (ttm) | -0.39 | Insider Own | 66.47% | Shs Outstand | 1.01B | Perf Week | -3.23% |
| Market Cap | 8.63B | Forward P/E | - | EPS next Y | 78.12% | Insider Trans | -0.07% | Shs Float | 0.34B | Perf Month | 28.29% |
| Enterprise Value | 9.23B | PEG | - | EPS next Q | -0.07 | Inst Own | 16.58% | Short Float | 38.42% | Perf Quarter | 264.78% |
| Income | -0.35B | P/S | 76.14 | EPS this Y | 32.63% | Inst Trans | 7.29% | Short Ratio | 3.64 | Perf Half Y | 223.94% |
| Sales | 0.11B | P/B | - | EPS next 5Y | - | ROA | -79.43% | Short Interest | 132.44M | Perf YTD | 323.74% |
| Book/sh | -0.49 | P/C | 35.52 | EPS past 3/5Y | 28.42% 15.6% | ROE | - | 52W High | -32.5% ($12.43) | Perf Year | 189.31% |
| Cash/sh | 0.24 | P/FCF | - | Sales past 3/5Y | 678.62% 299.74% | ROIC | -104.92% | 52W Low | 358.47% ($1.83) | Perf 3Y | 455.63% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 34.94% | Gross Margin | 85.63% | Volatility(W/M) | 7.51% 13.44% | Perf 5Y | -72.53% |
| Dividend TTM | - | EV/Sales | 81.46 | Sales Y/Y TTM | 668.31% | Oper. Margin | -226% | ATR (14) | 0.96 | Perf 10Y | 2.69% |
| Dividend Ex-Date | - | Quick Ratio | 5.08 | EPS Q/Q | 32.9% | Profit Margin | -310.18% | RSI (14) | 52.87 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.1 | Sales Q/Q | 406.95% | SMA20 | -4.7% ($8.8) | Beta | 0.01 | Target Price | $14.8 |
| Payout | - | Debt/Eq | - | Earnings | 2000000 | SMA50 | 29.75% ($6.47) | Rel Volume | 0.84 | Prev Close | $7.82 |
| Employees | 691 | LT Debt/Eq | - | EPS/Sales Surpr. | 21.57% -0.2% | SMA200 | 140.53% ($3.49) | Avg Volume(3M) | 36.38M | Price | $8.39 |
| IPO | 2015/7/28 | Option/Short | Yes/Yes | Trades | 77439 | Volume | 30,623,281 | Change | 7.29% |
뉴스 로딩 중...